State of Wisconsin Investment Board’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,559
Closed -$177K 2335
2024
Q1
$177K Sell
23,559
-51,968
-69% -$474K ﹤0.01% 2087
2023
Q4
$699K Sell
75,527
-17,558
-19% -$143K ﹤0.01% 1521
2023
Q3
$942K Buy
93,085
+2,673
+3% +$31.9K ﹤0.01% 1415
2023
Q2
$1.13M Sell
90,412
-6,296
-7% -$75K ﹤0.01% 1427
2023
Q1
$1.13M Sell
96,708
-30,234
-24% -$385K ﹤0.01% 1443
2022
Q4
$1.35M Buy
126,942
+20,842
+20% +$201K ﹤0.01% 1413
2022
Q3
$1.03M Buy
106,100
+3,799
+4% +$50.3K ﹤0.01% 1532
2022
Q2
$1.48M Sell
102,301
-22,699
-18% -$387K ﹤0.01% 1451
2022
Q1
$3.27M Hold
125,000
0.01% 1321
2021
Q4
$4.95M Hold
125,000
0.01% 1043
2021
Q3
$6.25M Hold
125,000
0.01% 959
2021
Q2
$6.94M Hold
125,000
0.01% 934
2021
Q1
$5.85M Hold
125,000
0.01% 960
2020
Q4
$5.44M Sell
125,000
-15,600
-11% -$575K 0.01% 953
2020
Q3
$5.15M Buy
+140,600
New +$4.77M 0.01% 924

Other funds holding HCAT

State of Wisconsin Investment Board's HCAT Position: Q2 2024 in Review

State of Wisconsin Investment Board sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 23,559 shares — an estimated $177K sold.

State of Wisconsin Investment Board first reported a position in HCAT in Q3 2020 and held it in 15 quarters. The position peaked at $6.94M in Q2 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

  • State of Wisconsin Investment Board reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 23,559 Health Catalyst shares in Q2 2024, an estimated $177K.
  • State of Wisconsin Investment Board first reported a position in Health Catalyst in Q3 2020 and held it in 15 quarters.
  • State of Wisconsin Investment Board's Health Catalyst position peaked at $6.94M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2024, filed 14 Aug 2024.